TP53 and non-small cell lung carcinoma: Moreover, in advanced NSCLC patients who did not receive ICI treatments, the association between different TP53 mutation categories and prognosis was investigated and compared in our cohort to determine whether the EAp53 stratification system could act as a prognostic factor in advanced NSCLC.